Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in Non-small Cell Lung Cancer (NSCLC) With Expansion Cohorts in NSCLC, Melanoma, and Colorectal Cancer (CRC)
Syndax Pharmaceuticals
Syndax Pharmaceuticals
UNC Lineberger Comprehensive Cancer Center
Vastra Gotaland Region
Bayer
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)